ACERUS PHARMACEUTICALS Debt to Equity vs. Market Capitalization

ASPCF -  USA Stock  

USD 0.03  0.00  0.00%

For ACERUS PHARMACEUTICALS profitability analysis, we use financial ratios and fundamental drivers that measure the ability of ACERUS PHARMACEUTICALS to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well ACERUS PHARMACEUTICALS CORP utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between ACERUS PHARMACEUTICALS's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of ACERUS PHARMACEUTICALS CORP over time as well as its relative position and ranking within its peers. Please continue to Trending Equities.

ACERUS Current Profitability Trends 

 
Refresh
The market value of ACERUS PHARMACEUTICALS is measured differently than its book value, which is the value of ACERUS that is recorded on the company's balance sheet. Investors also form their own opinion of ACERUS PHARMACEUTICALS's value that differs from its market value or its book value, called intrinsic value, which is ACERUS PHARMACEUTICALS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ACERUS PHARMACEUTICALS's market value can be influenced by many factors that don't directly affect ACERUS PHARMACEUTICALS underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ACERUS PHARMACEUTICALS's value and its price as these two are different measures arrived at by different means. Investors typically determine ACERUS PHARMACEUTICALS value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ACERUS PHARMACEUTICALS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

ACERUS PHARMACEUTICALS Market Capitalization vs. Debt to Equity Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining ACERUS PHARMACEUTICALS's current stock value. Our valuation model uses many indicators to compare ACERUS PHARMACEUTICALS value to that of its competitors to determine the firm's financial worth.
ACERUS PHARMACEUTICALS CORP is number one stock in debt to equity category among related companies. It is rated second in market capitalization category among related companies creating about  15,375,479  of Market Capitalization per Debt to Equity.

ACERUS Market Capitalization vs. Debt to Equity

Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
ACERUS PHARMACEUTICALS 
D/E 
 = 
Total Debt 
Total Equity 
2.61 %
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
ACERUS PHARMACEUTICALS 
Market Cap 
 = 
Shares Outstanding 
X  
Share Price 
40.13 M
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.

ACERUS Market Capitalization vs Competition

ACERUS PHARMACEUTICALS CORP is rated second in market capitalization category among related companies. Market capitalization of Drug Manufacturers—Specialty & Generic industry is presently estimated at about 22.58 Billion. ACERUS PHARMACEUTICALS adds roughly 40.13 Million in market capitalization claiming only tiny portion of equities under Drug Manufacturers—Specialty & Generic industry.
Capitalization  Workforce  Total debt  Revenue  Valuation

ACERUS PHARMACEUTICALS Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in ACERUS PHARMACEUTICALS, profitability is also one of the essential criteria for including it into their portfolios because, without profit, ACERUS PHARMACEUTICALS will eventually generate negative long term returns. The profitability progress is the general direction of ACERUS PHARMACEUTICALS's change in net profit over the period of time. It can combine multiple indicators of ACERUS PHARMACEUTICALS, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for mens and womens health. Acerus Pharmaceuticals Corporation was founded in 2008 and is headquartered in Mississauga, Canada. ACERUS PHARMACEUTICALS operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 10 people.

ACERUS Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on ACERUS PHARMACEUTICALS. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of ACERUS PHARMACEUTICALS position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the ACERUS PHARMACEUTICALS's important profitability drivers and their relationship over time.

Use ACERUS PHARMACEUTICALS in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ACERUS PHARMACEUTICALS position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ACERUS PHARMACEUTICALS will appreciate offsetting losses from the drop in the long position's value.

ACERUS PHARMACEUTICALS Pair Trading

ACERUS PHARMACEUTICALS CORP Pair Trading Analysis

Correlation analysis and pair trading evaluation for ACERUS PHARMACEUTICALS and Catalent. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  

Use Investing Themes to Complement your ACERUS PHARMACEUTICALS position

In addition to having ACERUS PHARMACEUTICALS in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Giant Impact Thematic Idea Now

Giant Impact
Giant Impact Theme
An experimental equal-weighted decomposition of large high potential stocks based on Macroaxis scoring framework. Giant Impact theme has 44 constituents.
View All  Next Launch Giant Impact
Please continue to Trending Equities. Note that the ACERUS PHARMACEUTICALS information on this page should be used as a complementary analysis to other ACERUS PHARMACEUTICALS's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Complementary Tools for ACERUS OTC Stock analysis

When running ACERUS PHARMACEUTICALS price analysis, check to measure ACERUS PHARMACEUTICALS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ACERUS PHARMACEUTICALS is operating at the current time. Most of ACERUS PHARMACEUTICALS's value examination focuses on studying past and present price action to predict the probability of ACERUS PHARMACEUTICALS's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ACERUS PHARMACEUTICALS's price. Additionally, you may evaluate how the addition of ACERUS PHARMACEUTICALS to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
To fully project ACERUS PHARMACEUTICALS's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of ACERUS PHARMACEUTICALS at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include ACERUS PHARMACEUTICALS's income statement, its balance sheet, and the statement of cash flows.
Potential ACERUS PHARMACEUTICALS investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although ACERUS PHARMACEUTICALS investors may work on each financial statement separately, they are all related. The changes in ACERUS PHARMACEUTICALS's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on ACERUS PHARMACEUTICALS's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.